Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Here’s Why These Five Stocks Are Trending Today

The US stock market is slightly up on Tuesday. While still up for the day, major indexes traded lower than in the morning, responding to Janet Yellen’s statement that the Federal Reserve would be cautious with interest rate hikes, given the current backdrop of uncertainty around the Brexit and the slowdown in the US job market.

Among the stocks posting large moves on Tuesday are IsoRay, Inc. (NYSEMKT:ISR), Kirby Corporation (NYSE:KEX), Bristow Group Inc (NYSE:BRS), Rex Energy Corporation (NASDAQ:REXX) and Twitter Inc (NYSE:TWTR). So, let’s take a look into the events behind the move of these stocks, and into what the hedge funds in our database think about the companies in question.

Through extensive research, we determined that imitating some of the picks of hedge funds and other institutional investors can help generate market-beating returns over the long run. The key is to focus on the small-cap picks of these investors, since they are usually less followed by the broader market and are less price-efficient. Our backtests that covered the period between 1999 and 2012, showed that following the 15 most popular small-caps among hedge funds can help a retail investor beat the market by an average of 95 basis points per month (see more details here).

stock, stocks, market, marketing, shares, share, global, chart, bonds, tax, capital, concept, graph, growth, background, rise, statistics, economy, bar, future, loss, business,


IsoRay Helped By Promising Results In Brain Tumors

Let’s start with IsoRay, Inc. (NYSEMKT:ISR), which has gained about 16% on Tuesday, driven by the announcement of positive results of its “Prospective trial of surgery and permanent intraoperative brachytherapy (S+BT) using a modular, biocompatible radiation implant for recurrent aggressive meningiomas,” at the Society of Neuro-Oncology Conference. The study in question assessed a new delivery method of Cesium-131 brachytherapy for patients with brain tumors. As most nano caps, IsoRay, Inc. (NYSEMKT:ISR) does not count on much hedge fund support. Out of the funds that we track, only Ken Griffin’s Citadel Investment Group disclosed a long position in the company as of the end of the first quarter. Over the period, the firm started a new position in the stock, comprising 104,184 shares, valued at $94,000 at the end of March.

Follow Isoray Inc. (NYSEMKT:ISR)
Trade (NYSEMKT:ISR) Now!

Kirby Gets Hit By Credit Suisse Downgrade

Next up is Kirby Corporation (NYSE:KEX), which has tumbled by more than 5% today, following a downgrade from Credit Suisse. The research firm cut the domestic tank barge operator to ‘Neutral’ from ‘Outperform’, citing decelerating volumes and the potential for weakness in the company’s coastal business. Credit Suisse has set a $60 price target for the stock. During the first quarter, Kirby Corporation (NYSE:KEX) saw the number of funds in our database long its stock decline by 31% to 20. Among those who closed out their stakes some time between January and March, was Phill Gross and Robert Atchinson’s Adage Capital Management, which held 234,946 shares at the end of 2015.

Follow Kirby Corp (NYSE:KEX)
Trade (NYSE:KEX) Now!

On the next page we will look into three more stocks posting big moves on Tuesday.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.